Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786370 · ClinicalTrials.gov registry record · Phase 4
Dexmedetomidine vs. Propofol for Cataract Surgery
A Phase 4 study, sponsored by The Cooper Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00786370: Completed Phase 4 study, sponsored by The Cooper Health System.
NCT00786370 is a Phase 4 study that has completed, run by The Cooper Health System. The registered enrollment target is 24 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00786370, a Phase 4 study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The use of dexmedetomidine in cataract surgery is still limited and to date only one study has examined anesthetic technique in this patient population. This pilot study will therefore compare the use of dexmedetomidine and propofol in subjects undergoing cataract surgery. The primary endpoint will be based on simple cardiorespiratory measures often associated with complications from sedation as well as assessment of the achieved sedation by the attending anesthesiologist and surgeon.
Interventions
- DRUG Propofol
- DRUG dexmedetomidine
- DRUG Dexemedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-04 |
| Phase | Phase 4 |
What the finished NCT00786370 record still lists
NCT00786370 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Propofol is the first listed.
NCT00786370 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00786370 about?
NCT00786370 is a clinical study titled "Dexmedetomidine vs. Propofol for Cataract Surgery". The use of dexmedetomidine in cataract surgery is still limited and to date only one study has examined anesthetic technique in this patient population. This pilot study will therefore compare the use of dexmedetomidine and propofol in subjects undergoing cataract surgery. The primary endpoint will ...
What is the current status of trial NCT00786370?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2008-04. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00786370?
The interventions under investigation include: Propofol (DRUG), dexmedetomidine (DRUG), Dexemedetomidine (DRUG).
Who is sponsoring clinical trial NCT00786370?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00786370's enrollment target sits among peer trials
24 1699th of 2000 higher than 276 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia